The effect of choice of platinum on survival and factors affecting survival in metastatic small cell lung cancer: A Single Center Experience

The effect of choice of platinum on survival and factors affecting survival in metastatic small cell lung cancer: A Single Center Experience

INTRODUCTION: In this retrospective study, we aimed to analyze the effect of choice of platinum chemotherapy (carboplatin vs. cisplatin) on survival in patients with small cell lung cancer(SCLC) and to identify the factors affecting survival. METHODS: A total of 87 metastatic SCLC patients with avai...

Full description

Bibliographic Details
Main Authors:	Ayşegül Sakin, mehmet naci aldemir, murat alay
Format:	Article
Language:	English
Published:	Van Yuzuncu Yil University, School of Medicine 2021-01-01
Series:	Van Tıp Dergisi
Subjects:	small cell lung cancer prognostic factors cisplatin carboplatin survival
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-46244

Similar Items

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Comparison of survival and adverse effect profile in patients with esophageal cancer treated with the combination of carboplatin and paclitaxel vs. 5-flourouracil and cisplatin
by: N. Nisar, et al.
Published: (2022-09-01)

Chemotherapy for small cell lung cancer: a comprehensive review
by: Syed Mustafa Karim, et al.
Published: (2012-04-01)

Factors Affecting Recurrence-free Survival in Gastric Gastrointestinal Stromal Tumors: A Single Center Experience
by: Ayşegül Sakin, et al.
Published: (2020-09-01)

Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab
by: Reyes Bernabé, et al.
Published: (2024-01-01)

Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging
by: Aydin Sinem, et al.
Published: (2022-05-01)

Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
by: Ayşegül Sakin, et al.
Published: (2020-10-01)

Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
by: Canling Lin, et al.
Published: (2022-10-01)

Editorial: The role of platinum-based antitumor prodrugs in medicinal inorganic chemistry
by: Nicola Margiotta, et al.
Published: (2023-03-01)

Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluation
by: Suzanne van der Gaag, et al.
Published: (2024-04-01)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
by: Ken Masubuchi, et al.
Published: (2022-10-01)

Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds
by: Loredana G. Marcu
Published: (2022-02-01)

Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era
by: Shintaro Yokoyama, et al.
Published: (2017-05-01)

Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors
by: Alberto Romano, et al.
Published: (2023-01-01)

Pharmacotherapy of small cell lung cancer: Current state-of-the-art
by: Tatyana A. Berezhnova, et al.
Published: (2023-03-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
by: Keita Sekine, et al.
Published: (2024-11-01)

Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
by: Brittany P. Rickard, et al.
Published: (2023-12-01)

Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia
by: Evelien G. E. Hurkmans, et al.
Published: (2023-01-01)

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre
by: Sue Cheeseman, et al.
Published: (2020-02-01)

Adenosine Overcomes Triple-Negative Breast Cancer Resistance to Platinum-Derived Chemotherapeutic Drugs
by: Ana Cerquido, et al.
Published: (2022-11-01)

Dynamic assessment of long-term survival in survivors with stage III non-small cell lung cancer: a novel conditional survival model with a web-based calculator
by: Xiangdi Meng, et al.
Published: (2025-01-01)

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
by: Francesco Trevisani, et al.
Published: (2022-04-01)

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy
by: Macus Tien Kuo, et al.
Published: (2021-06-01)

Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer
by: Serdar ATA, et al.
Published: (2023-09-01)

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients
by: Ting Zhai, et al.
Published: (2022-12-01)

Quality of life predicts survival in patients with non-small cell lung cancer
by: Li Tsai-Chung, et al.
Published: (2012-09-01)

DISSEMINATED NON SMALL-CELL LUNG CANCER: POSSIBILITIES OF DRUG THERAPY IN THE FIRST DECADE OF THE XXI CENTURY
by: A. M. Garin, et al.
Published: (2014-07-01)

DISSEMINATED NON SMALL-CELL LUNG CANCER: POSSIBILITIES OF DRUG THERAPY IN THE FIRST DECADE OF THE XXI CENTURY
by: A. M. Garin, et al.
Published: (2014-07-01)

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)

The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
by: Deyan N. Davidov
Published: (2012-02-01)

Hypersensitivity and cross-reactivity to cisplatin and carboplatin
by: Gholamreza Faridaalaee, et al.
Published: (2016-07-01)

Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
by: Tingshan He, et al.
Published: (2022-01-01)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
by: Satoshi Wasamoto, et al.
Published: (2023-01-01)

Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database
by: Jie Yang, et al.
Published: (2023-02-01)

Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy
by: Jiafeng Liu, et al.
Published: (2023-12-01)

Advanced non-small cell lung cancer in elderly patients: The standard every 3-weeks versus weekly paclitaxel with carboplatin
by: Hala Mohamed El-Shenshawy, et al.
Published: (2012-10-01)

The Effect of Prognostic Nutritional Index on Prognosis in Small Cell Lung Cancer: Single Center Experience
by: Esma TÜRKMEN BEKMEZ
Published: (2020-08-01)

Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma
by: Guanyu Huang, et al.
Published: (2024-01-01)

Comparison of Chemotherapy Regiments between Cisplatin Etoposide and Cisplatin-Docetaxel on 2-Year and Progression-Free Survival in Late-Stage Non-Small Cell Lung Cancer Patients
by: Salman Paris Harahap, et al.
Published: (2016-06-01)